FDA Approved Treatment Option - Non Small Cell Lung Cancer
An Approved Treatment Option For Previously Treated Advanced NSCLC. Learn More.
Lung Cancer Rx Receives FDA Approval
A lung cancer drug has received regular approval from the US Food and Drug Administration (FDA).
Approved: First Biosimilar Rx for Cancer
The US Food and Drug Administration (FDA) has approved the United States' first biosimilar drug to treat cancer.
Vitamin B and Lung Cancer: A Possible Link
Your high-dose B vitamin supplement may be raising your risk of lung cancer, a new study found.
Cancer Rx Combo Gets Green Light
The US Food and Drug Administration (FDA) has approved two new cancer treatments.
No Such Thing as a Safe Cigarette
Despite their marketing as a "healthier" option, so-called "light" filtered cigarettes may actually be causing more cases of a certain type of lung cancer, a new study found.
Lung Cancer Gets New Treatment
The US Food and Drug Administration (FDA) has approved a new medication to treat non-small cell lung cancer.
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
Plus One for Lung Cancer Surgery
Surgery for patients with late-stage, non-small cell lung cancer (NSCLC) may increase survival, but many patients aren't having the procedure, a new study found.
Good News for Older Patients with Lung Cancer
Post-surgery survival rates for older patients with lung cancer may be improving, a new study found.